Behr, J., Prasse, A., & Kreuter, M. (2017). Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF): A randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial. BioMed Central. https://doi.org/10.1186/s12890-017-0462-y
Chicago-Zitierstil (17. Ausg.)Behr, Jürgen, Antje Prasse, und Michael Kreuter. Exploring Efficacy and Safety of Oral Pirfenidone for Progressive, Non-IPF Lung Fibrosis (RELIEF): A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Trial. London: BioMed Central, 2017. https://doi.org/10.1186/s12890-017-0462-y.
MLA-Zitierstil (9. Ausg.)Behr, Jürgen, et al. Exploring Efficacy and Safety of Oral Pirfenidone for Progressive, Non-IPF Lung Fibrosis (RELIEF): A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Trial. BioMed Central, 2017. https://doi.org/10.1186/s12890-017-0462-y.